• Product NameBindarit
• Brief DescriptionInhibitors
• Purification98.71%
• Biological ActivityBindarit exhibits selective inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8.
• Target NameCCR inhibitor
• CAS No. 130641-38-2
• Calculated MW 324.37
• Formulation C19H20N2O3
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Metabolism
  SMILES:CC(C)(OCC1=NN(CC2=CC=CC=C2)C2=C1C=CC=C2)C(O)=O |c:11,13,16,19,21,t:5,9|
  Pathways:Immunology/Inflammation; Microbiology&virology
  Receptor:MCP-1/CCL2; MCP-2/CCL8; MCP-3/CCL7
  Boling pt:
  Melting pt:
  Solubility:DMSO:65 mg/mL (200.38 mM)Ethanol:65 mg/mL (200.38 mM)Water:<1 mg/mL (<1 mM)
  Appearance:
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Zoja C, et al. Kidney Int, 1998, 53(3), 726-734.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting